Osaic Holdings’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-6,344
Closed -$115K 6610
2020
Q2
$115K Sell
6,344
-11,647
-65% -$162K ﹤0.01% 3595
2020
Q1
$120K Buy
+17,991
New +$224K ﹤0.01% 3326

Osaic Holdings's PTLA Position: Q3 2020 in Review

Osaic Holdings sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 6,344 shares — an estimated $115K sold.

Osaic Holdings first reported a position in PTLA in Q1 2020 and held it in 2 quarters. The position peaked at $120K in Q1 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Osaic Holdings reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Osaic Holdings sold 6,344 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $115K.
  • Osaic Holdings first reported a position in Portola Pharmaceuticals, Inc. in Q1 2020 and held it in 2 quarters.
  • Osaic Holdings's Portola Pharmaceuticals, Inc. position peaked at $120K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Osaic Holdings's 13F filing for Q3 2020, filed 12 Nov 2020.